J&J executive testifies DePuy ASR recalled because of clinical needs, not failure, the Rottenstein Law Group reports

(PRWEB) January 31, 2013

The Rottenstein Law Group, which represents DePuy ASR recall clients, is closely monitoring the proceedings of the Los Angeles DePuy ASR hip trial (In re: Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court). Most recently, the jury heard testimony from a DePuy executive who denied that the recall occurred because the device was faulty. Andrew Ekdahl, president of Johnson & Johnson’s DePuy, said in videotaped testimony that the 93,000 DePuy ASR hip implants were recalled worldwide because they did not meet the clinical needs of the market and not because they were unsafe," according to a Bloomberg story.

“Thousands of people believe they were harmed by the DePuy ASR,” said Rochelle Rottenstein, principal of the Rottenstein Law Group. “It is important that these allegations are thoroughly explored in court.”

Loren Kransky, 65, of North Dakota, alleges that the DePuy ASR caused him metal poisoning, among other problems, according to court records. DePuy asserts that Kransky’s health problems are unrelated to his now-removed hip implant, according to Bloomberg. There are more than 10,000 DePuy ASR lawsuits pending across the United States, about 7,000 of which are consolidated for pretrial proceedings in multidistrict litigation in the United States District Court for the Northern District of Ohio (MDL-2197).

Read more: DePuy ASR Lawsuit Update: J&J executive testifies DePuy ASR recalled because of clinical needs, not failure, the Rottenstein Law Group reports